XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Revenues:        
Revenues $ 5,596 $ 6,512 $ 16,332 $ 20,158
Costs and expenses:        
Cost of goods sold 1,086 1,032 3,283 3,115
Research and development expenses 939 789 3,068 2,584
Selling, general and administrative expenses 948 879 2,925 2,626
Total costs and expenses 2,973 2,700 9,276 8,325
Income from operations 2,623 3,812 7,056 11,833
Interest expense (264) (291) (820) (821)
Other income (expense), net 305 150 547 391
Income before provision for income taxes 2,664 3,671 6,783 11,403
Provision for income taxes 565 959 1,326 2,923
Net income 2,099 2,712 5,457 8,480
Net income (loss) attributable to noncontrolling interest 2 (6) 5 (13)
Net income attributable to Gilead $ 2,097 $ 2,718 $ 5,452 $ 8,493
Net income per share attributable to Gilead common stockholders - basic (usd per share) $ 1.62 $ 2.08 $ 4.19 $ 6.50
Shares used in per share calculation - basic (in shares) 1,296 1,306 1,302 1,307
Net income per share attributable to Gilead common stockholders - diluted (usd per share) $ 1.60 $ 2.06 $ 4.15 $ 6.44
Shares used in per share calculation - diluted (in shares) 1,307 1,319 1,313 1,319
Cash dividends declared (usd per share) $ 0.57 $ 0.52 $ 1.71 $ 1.56
Product sales        
Revenues:        
Product revenue $ 5,455 $ 6,402 $ 15,996 $ 19,825
Royalty, contract and other revenues        
Revenues:        
Revenues $ 141 $ 110 $ 336 $ 333